ArticleEMBO reports2019

A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.

Jihee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.